<DOC>
	<DOC>NCT00444834</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy of the EgaletÂ® controlled release formulation to an immediate release Carvedilol tablet.</brief_summary>
	<brief_title>A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Have a diagnosis of mild or moderate primary hypertension Be able to tolerate a 2 week washout phase followed by a 2 week Placebo run in phase Be minimum 18 years of age Be intolerant to alfa or betablockers Have secondary causes of hypertension Be taking more than two antihypertensive medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>